$AMGN News

Pfizer Vs. Amgen: Bet That Pfizer’s Seagen Integration Leads to Long-Term Oncology Alpha Over Amgen

Amgen (AMGN) Stock May Be 47% Undervalued After Enbrel Price Cap Ruling

UBS Maintains Buy on Amgen, Raises Price Target to $420

Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It

Guggenheim Maintains Neutral on Amgen, Raises Price Target to $343

Truist Raises its Price Target on Amgen (AMGN)

Amgen (AMGN): Buy, Sell, or Hold Post Q1 Earnings?

Morgan Stanley Maintains Equal-Weight on Amgen, Lowers Price Target to $333

Amgen (AMGN) Recalls Put Its Valuation Story Back In Focus

Did Enbrel’s Price Cap Reprieve and New Recalls Just Rebalance Amgen’s (AMGN) Risk‑Reward Profile?

How Safe Is Amgen's Dividend?

Amgen (AMGN) Recalls Sensipar And Corlanor In Broad US Quality Sweep

If You Invested $100 In Amgen Stock 15 Years Ago, You Would Have This Much Today

Truist Securities Maintains Hold on Amgen, Raises Price Target to $340

Amgen (AMGN) Stock Dips While Market Gains: Key Facts

Amgen (AMGN) Upgraded to Buy: What Does It Mean for the Stock?

Cantor Fitzgerald Reiterates Neutral on Amgen, Maintains $350 Price Target

Amgen (AMGN) Stock Is Up, What You Need To Know

Medical journal retracts Tavneos pivotal paper amid wider regulatory clampdown

Mizuho Highlights Amgen (AMGN) Pipeline Potential With MariTide and Olpasiran